Author:
Peñuelas-Urquides Katia,Castorena-Torres Fabiola,Ramírez Beatriz Silva,León Mario Bermúdez de
Reference44 articles.
1. WHO. Global Tuberculosis Report. Switzerland: World Health Organization; 2016
2. Machado D, Couto I, Perdigao J, Rodrigues L, Portugal I, Baptista P, et al. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PloS One. 2012;4:e34538
3. Gupta R, Espinal M. A prioritised research agenda for DOTS‐Plus for multidrug‐resistant tuberculosis (MDR‐TB). The International Journal of Tuberculosis and Lung Disease. 2003;5:410-414
4. Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respiratory Research. 2001;3:164-168
5. Lawn SD, Nicol MP. Xpert(R) MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiology. 2011;9:1067-1082
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献